Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer (vol 77, pg 5846, 2017)

被引：0
|
作者：
Salvador, Fernando
Martin, Alberto
Lopez-Menendez, Celia
Moreno-Bueno, Gema
Santos, Vanesa
Vazquez-Naharro, Alberto
Santamaria, Patricia G.
Morales, Saleta
Dubus, Pierre R.
Muinelo-Romay, Laura
Lopez-Lopez, Rafael
Tung, Jason C.
Weaver, Valerie M.
Portillo, Francisco
Cano, Amparo
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 06期
关键词：
D O I：
10.1158/0008-5472.CAN-23-0127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：974 / 974
页数：1
相关论文
共 50 条
  • [31] Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization
    Canesin, G.
    Cuevas, E. P.
    Santos, V.
    Lopez-Menendez, C.
    Moreno-Bueno, G.
    Huang, Y.
    Csiszar, K.
    Portillo, F.
    Peinado, H.
    Lyden, D.
    Cano, A.
    ONCOGENE, 2015, 34 (08) : 951 - 964
  • [32] Clinical significance of Lysil oxidase-like 2 (LOXL 2) in breast cancer
    Ahn, S. G.
    Lee, H. M.
    Hwang, S. H.
    Lee, S. A.
    Jeong, J.
    Lee, H-E
    CANCER RESEARCH, 2012, 72
  • [33] Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization
    G Canesin
    E P Cuevas
    V Santos
    C López-Menéndez
    G Moreno-Bueno
    Y Huang
    K Csiszar
    F Portillo
    H Peinado
    D Lyden
    A Cano
    Oncogene, 2015, 34 : 951 - 964
  • [34] Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells
    Hollosi, Peter
    Yakushij, Jana K.
    Fong, Keith S. K.
    Csiszar, Katalin
    Fong, Sheri F. T.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (02) : 318 - 327
  • [35] EXPRESSION OF LYSYL OXIDASE-LIKE 2 (LOXL2) CORRELATES WITH LEFT ATRIAL SIZE AND FIBROTIC GENE EXPRESSION IN HUMAN ATRIAL FIBRILLATION
    Zhong, Hongyan
    Liang, Xiao-Huan
    Neef, Stefan
    Popov, Aron
    Maier, Lars S.
    Yao, Lina
    Belardinelli, Luiz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A285 - A285
  • [36] A Monoclonal Antibody Directed at the Lysyl Oxidase-Like 2 (LOXL2) Enzyme Appears Safe and Well Tolerated in Patients with Liver Disease
    Talal, Andrew
    Feron-Rigodon, Marlene
    Madere, Jeannine
    He, Lin
    Winter, Maria
    McHutchison, John G.
    Bornstein, Jeffrey
    HEPATOLOGY, 2012, 56 : 809A - 809A
  • [37] Study of the gastroenteropancreatic neuroendocrine tumor (gep-net) microenvironment beyond angiogenesis: The role of lysyl oxidase-like 2 (LOXL2).
    Barriuso, Jorge
    Bernal, Elsa
    Pastrian, Laura Guerra
    Grande, Enrique
    Castellano, Daniel E.
    Capdevila, Jaume
    Alvarez-Escola, Cristina
    Martinez, Jaime
    Diaz, Esther
    Heredia, Victoria
    Castell, Jose
    Feliu, Jaime
    Burgos, Emilio
    Mendiola, Marta
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1
    Kim, Boh-Ram
    Dong, Seung Myung
    Seo, Seung Hee
    Lee, Ji-Hae
    Lee, Jae Myun
    Lee, Seung-Hoon
    Rho, Seung Bae
    CELLULAR SIGNALLING, 2014, 26 (09) : 1765 - 1773
  • [39] Lysyl oxidase-like 2 promotes hepatocellular carcinoma metastasis by remodelling the tumor and metastatic microenvironments
    Wong, Carmen Chak Lui
    Ng, Irene Oi-Lin
    CANCER RESEARCH, 2014, 74 (19)
  • [40] Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma
    Lv, Guo-Qing
    Zou, Hai-Ying
    Liao, Lian-Di
    Cao, Hui-Hui
    Zeng, Fa-Min
    Wu, Bing-Li
    Xie, Jian-Jun
    Fang, Wang-Kai
    Xu, Li-Yan
    Li, En-Min
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2014, 92 (05): : 379 - 389
12345